Skip to content
Disclosery

ACCIPITER CAPITAL MANAGEMENT, LLC

Follow

13F filer, CIK 1280190, Jersey City, NJ

ACCIPITER CAPITAL MANAGEMENT, LLC reported $125,717,000 across 8 holdings for the quarter ended 2016-12-31, in a 13F-HR filed 2017-02-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000921895-17-000370

Period
2016-12-31
Reported value
$126M
Holdings
8
Top 10 weight
100%
New
2
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CYHadded+1,332,364$7.45M
THCnew+300,000$4.45M
QUORUM HEALTH CORPadded+399,190$2.9M
TEVAadded+28,117$1.02M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VALEANT PHARMACEUTICALS INTLreduced-696,700-$10.1M
SHIRE PLCexited-45,293-$8.78M
PRGOreduced-65,654-$5.46M
FORESIGHT ENERGY LPreduced-577,546-$3.74M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2016

Share positions as resolved from 13F-HR 0000921895-17-000370, largest first. % of portfolio is the value over $113,375,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
FORESIGHT ENERGY LPFORESIGHT ENERGY LPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: restricted; 2015Q2: restricted; 2015Q3: restricted; 2015Q4: restricted; 2016Q1: restricted; 2016Q2: restricted; 2016Q3: restricted; 2016Q4: 7,836,251 shares 7,836,251$50.7M44.72%-577,546
VALEANT PHARMACEUTICALS INTLVALEANT PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: restricted; 2015Q2: restricted; 2015Q3: restricted; 2015Q4: restricted; 2016Q1: restricted; 2016Q2: restricted; 2016Q3: restricted; 2016Q4: 1,214,910 shares 1,214,910$17.6M15.56%-696,700
CYHCOMMUNITY HEALTH SYS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: restricted; 2015Q2: restricted; 2015Q3: restricted; 2015Q4: restricted; 2016Q1: restricted; 2016Q2: restricted; 2016Q3: restricted; 2016Q4: 2,787,506 shares 2,787,506$15.6M13.74%+1,332,364Timeline
PRGOPERRIGO CO PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: restricted; 2015Q2: restricted; 2015Q3: restricted; 2015Q4: restricted; 2016Q1: restricted; 2016Q2: restricted; 2016Q3: restricted; 2016Q4: 141,637 shares 141,637$11.8M10.4%-65,654Timeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: restricted; 2015Q2: restricted; 2015Q3: restricted; 2015Q4: restricted; 2016Q1: restricted; 2016Q2: restricted; 2016Q3: restricted; 2016Q4: 204,030 shares 204,030$7.4M6.52%+28,117Timeline
QUORUM HEALTH CORPQUORUM HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: restricted; 2015Q2: restricted; 2015Q3: restricted; 2015Q4: restricted; 2016Q1: restricted; 2016Q2: restricted; 2016Q3: restricted; 2016Q4: 800,000 shares 800,000$5.82M5.13%+399,190
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: restricted; 2015Q2: restricted; 2015Q3: restricted; 2015Q4: restricted; 2016Q1: restricted; 2016Q2: restricted; 2016Q3: restricted; 2016Q4: 300,000 shares 300,000$4.45M3.93%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
VALEANT PHARMACEUTICALS INTLVALEANT PHARMACEUTICALS INTL COMcall850,000$12.3Mnew

Sold out in Q4 2016

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
UNHUNITEDHEALTH GROUP INC515,700$72.2Mput
SHIRE PLCSHIRE PLC45,293$8.78Mshares

How Q4 2016 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000921895-17-000370 base2017-02-14acceptance time not in the bulk data set